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Abstract
Solitary fibrous tumors are predominantly benign and 
are most commonly found in the thoracic cavity and 
pleura; while reports exist in the literature of malig-
nant solitary fibrous tumors and those located in extra-
thoracic organs, these cases are considered extremely 
rare. Herein, a case is reported of a malignant solitary 
fibrous tumor involving the liver that was diagnosed 
and treated in a 62-year-old woman. The patient pre-
sented with complaints of upper abdominal pain and 
unintentional weight loss. Computed tomography scan 
of the abdomen revealed a remarkably large mass, 
measuring 15 cm × 10 cm × 20 cm, which appeared 
to be unrelated to any particular organ. The intraop-
erative finding of a wide communication with the left 
liver suggested hepatic origin, and served as an indica-
tor for tumor resection via  left hemihepatectomy. The 
diagnosis of solitary fibrous tumor and its malignant 
nature was confirmed by histological and immunohisto-
chemical examination of the resected tissues. Hepatic 
solitary fibrous tumor is very rare, and surgery remains 
the mainstay of treatment. Due to limited reports of 
such tumors in the literature, little can be said about 
the benefit of adjuvant therapy and prognosis for the 
rare cases with malignant histological findings.
© 2013 Baishideng. All rights reserved.
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Core tip: Solitary fibrous tumors are predominantly be-
nign and most commonly found in the thoracic cavity 
and pleura, but occasionally show malignant charac-
teristics and occur in extrathoracic organs. A malignant 
solitary fibrous tumor involving the liver that was di-
agnosed in a 62-year-old woman and treated by surgi-
cal resection is reported here. Solitary fibrous tumor 
is very rare in a hepatic location, and surgery is the 
mainstay of treatment. Due to limited reports of such 
tumors in the literature, little can be said about the 
benefit of adjuvant therapy and prognosis for the rare 
cases with malignant histological findings.
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INTRODUCTION
Solitary fibrous tumor (SFT) is a rare mesenchymal neo-
plasm. Whereas most of  the SFTs reported in the litera-
ture have occurred in the thoracic cavity and pleura, cases 
of  SFTs involving extrathoracic organs exist[1-3]. The ma-
jority of  SFTs are benign and patients commonly present 
as asymptomatic; however, excessive size or involvement 
of  vital structures may lead to paraneoplastic and local 
symptoms[1,2,4,5]. Surgery remains the treatment of  choice, 
and little is known about the benefits of  adjuvant therapy 
for those rare cases with histological findings that indi-
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cate malignancy[6]. Herein, we report a very rare case of  a 
malignant SFT involving the liver.
CASE REPORT
A 62-year-old woman presented at our hospital with 
complaints of  upper abdominal pain persisting for sev-
eral days and unintended weight loss that had occurred 
over the past month approximately. The patient’s surgical 
history included resection of  the transverse colon in 1984 
to remove an adenocarcinoma, for which the results of  
follow-up examinations were unremarkable.
Physical examination upon admission revealed ca-
chexia and a palpable large, firm mass in the epigastrium 
region that was roughly the size of  a coconut. Laboratory 
tests showed normal complete blood cell count and slight 
thrombocytosis (525 G/L vs normal range: 150-400 G/L), 
as well as normal levels of  all liver function markers ex-
cept for C-reactive protein, which was elevated (29 mg/L 
vs normal range: 0-5 mg/L).
Computed tomography (CT) scan revealed a remark-
ably large single circumscribed intraabdominal tumor 
(Figure 1) without evidence of  lymphatic metastases; 
the imaging analysis provided no indication of  tumor 
relation to any particular organ. The presence of  distant 
metastases was excluded by findings from additional CT 
scanning of  the thoracic cavity. A median laparotomy 
was performed. The intraoperative findings of  a wide 
communication between the tumor and the left liver and 
absence of  penetration into adjacent organs suggested 
hepatic origin, and a left hemihepatectomy was carried 
out. The gross specimen was a large, lobulated, sharply 
demarcated tumor with obvious intratumoral necrotic 
areas (Figure 2).
Histological examination revealed the specimen to be 
a well-circumscribed mesenchymal tumor adjacent to the 
hepatic parenchyma and capsule. The tumor was com-
posed of  short spindly and ovoid cells arranged in a ran-
dom pattern amidst a variable collagenous background 
with hemangiopericytoma-like thin-walled ectatic blood 
vessels (Figure 3). In addition, areas of  high cellularity 
with nuclear crowding, cytological atypia, tumor necrosis, 
and increased mitotic rate (up to six mitotic figures per 10 
high-power fields) were observed. Immunohistochemi-
cal analysis showed positivity for CD34, CD99 and bcl-2, 
and negativity for cytokeratin, CD117, desmin, S-100 
and actin. The diagnosis was made of  a malignant SFT 
involving the liver.
The postoperative course was uneventful, although 
the recovery duration was slightly protracted because of  
the patient’s poor nutritional status.
DISCUSSION
SFTs are most commonly found in the thoracic cavity 
and pleura, but have also been reported in various ex-
trathoracic organs, including the upper respiratory tract, 
orbits, soft tissue, abdomen, and breast[1-3]. Very rarely do 
SFTs involve the liver, and the incidence of  these tumors 
is unknown[7]. The majority of  hepatic SFT diagnoses 
have been in adults (mean age: 57.5 years) and there ap-
pears to be a strong bias towards the female sex (2:1)[4].
While most cases present as asymptomatic, some cases, 
such as our patient described herein, show abdominal 
fullness and a palpable mass[5]. Other symptoms that have 
been described include paraneoplastic hypoglycemia, fa-
tigue, and weight loss[4]. From a biochemical perspective, 
the association of  neoplasms with thrombocytosis and 
elevated C-reactive protein level is well known[8,9], and the 
presence of  a tumor may be suspected when these find-
ings are present. However, definitive diagnosis of  SFT 
is based on a characteristic panel of  histological and im-
munohistochemical features. Histologically, SFT is com-
posed of  spindly to ovoid cells, possibly of  fibroblastic 
origin, which are arranged in a haphazard “patternless” 
pattern and intimately intertwined by collagen fibers 
of  various thicknesses, and associated with numerous 
hemangiopericytoma-like dilated thin-walled blood ves-
sels. Immunohistochemically, SFT is positive for CD34, 
CD99, and bcl-2[10]. The diagnosis of  SFT was made in 
the present case according to these characteristic immu-
nohistochemical findings and histological features.
Whereas most of  the SFTs reported in the literature 
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Figure 1  Computed tomography scan of the abdomen showing a well-cir-
cumscribed, solitary, large mass (15 cm × 10 cm × 20 cm) adjacent to the 
left liver lobe. The claw sign of hepatic tissue suggests intrahepatic localiza-
tion. Notable features include hypervascularity, heterogeneous enhancement, 
and smooth margins.
Figure 2  Gross specimen is a bulky neoplasm attached to the liver capsule.
have been benign (> 80%), their malignant potential is 
largely unknown[2]. About 10%-15% of  SFTs behave ag-
gressively. Although no strict correlation has been found 
between the SFTs’ morphological features and malig-
nancy, the current World Health Organization (WHO) 
classification criteria of  soft tissue tumors is used to iden-
tify malignant SFT; these criteria include hypercellularity, 
cytological atypia, tumor necrosis, high mitotic rate (four 
or more mitotic figures per 10 high-power fields), and/or 
infiltrative margins[10,11]. The resected tumor specimen-
from our case showed features of  high cellularity with 
nuclear crowding, moderate to marked cellular atypia, 
up to six mitotic figures per 10 high-power fields and 
tumor necrosis, fulfilling the WHO criteria for malignant 
SFT. The imaging features previously reported for other 
benign and malignant SFTs involving the liver seem to 
overlap, and there is no distinctive radiological criterion 
for diagnosing malignancy, excepting the presence of  dis-
tant metastases[12].
Malignant SFTs involving the liver are currently 
treated by surgical resection, with the aim of  obtaining 
a margin-negative specimen[6]. Because the number of  
cases reported to date is small, evidence of  the benefit of  
adjuvant therapy is lacking and its use remains controver-
sial[2,13]. As the biological behavior of  these tumors and 
the patients’ prognosis after treatment have not been well 
defined[5], careful follow-up is mandatory.
In conclusion, malignant SFT involving the liver is 
very rare. Nevertheless, it should be considered as a po-
tential differential diagnosis when a single large hepatic 
mass is present. Definitive diagnosis is based on histo-
pathological and immunohistochemical findings, andsur-
gery remains the mainstay of  treatment. The rarity of  
these cases and limited reports in the literature preclude 
any significant speculation regarding the benefit of  adju-
vant therapy and patient prognosis.
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Figure 3  Histological findings indicative of malignant solitary fibrous tumor. A: Hypo- and hypercellular patternless growth patterns [hematoxylin and eosin (HE), 
× 40]; B: Short spindly to ovoid tumor cells in a collagenous background (HE, × 200); C: Immunohistochemical staining with positive detection of CD34 (HE, × 200); D: 
Multifocal areas of necrosis (HE, × 200); E: Hypercellularity, cytologic atypia, and increased mitotic activity (HE, × 400).
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